GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia
Sun Summit Commences Drilling and Provides Exploration Update from the JD Project in BC's Toodoggone District